AU1390699A - A method of increasing nucleic acid synthesis with ultrasound - Google Patents

A method of increasing nucleic acid synthesis with ultrasound

Info

Publication number
AU1390699A
AU1390699A AU13906/99A AU1390699A AU1390699A AU 1390699 A AU1390699 A AU 1390699A AU 13906/99 A AU13906/99 A AU 13906/99A AU 1390699 A AU1390699 A AU 1390699A AU 1390699 A AU1390699 A AU 1390699A
Authority
AU
Australia
Prior art keywords
ultrasound
nucleic acid
acid synthesis
increasing nucleic
increasing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU13906/99A
Inventor
Thomas Mccreery
David Sadewasser
Evan C. Unger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ImaRx Pharmaceutical Corp
Original Assignee
ImaRx Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ImaRx Pharmaceutical Corp filed Critical ImaRx Pharmaceutical Corp
Publication of AU1390699A publication Critical patent/AU1390699A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00—Ultrasound therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicinal Preparation (AREA)
AU13906/99A 1997-11-17 1998-11-11 A method of increasing nucleic acid synthesis with ultrasound Abandoned AU1390699A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97154097A 1997-11-17 1997-11-17
US08971540 1997-11-17
PCT/US1998/023843 WO1999025385A1 (en) 1997-11-17 1998-11-11 A method of increasing nucleic acid synthesis with ultrasound

Publications (1)

Publication Number Publication Date
AU1390699A true AU1390699A (en) 1999-06-07

Family

ID=25518528

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13906/99A Abandoned AU1390699A (en) 1997-11-17 1998-11-11 A method of increasing nucleic acid synthesis with ultrasound

Country Status (2)

Country Link
AU (1) AU1390699A (en)
WO (1) WO1999025385A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582392B1 (en) 1998-05-01 2003-06-24 Ekos Corporation Ultrasound assembly for use with a catheter
US6794369B2 (en) 1997-12-31 2004-09-21 Pharmasonics Methods, systems, and kits for intravascular nucleic acid delivery
US6372498B2 (en) 1997-12-31 2002-04-16 Pharmasonics, Inc. Methods, systems, and kits for intravascular nucleic acid delivery
BR9916969A (en) 1999-01-27 2001-11-06 Pfizer Prod Inc Ketolide antibiotics
JP2004532205A (en) * 2001-03-22 2004-10-21 クロモス・モレキユラー・システムズ・インコーポレーテツド Delivery of nucleic acid molecules to cells and method for evaluating the same
ATE319378T1 (en) 2001-12-03 2006-03-15 Ekos Corp CATHETER WITH MULTIPLE ULTRASONIC EMITTING PARTS
US7141044B2 (en) 2001-12-11 2006-11-28 Ekos Corporation Alternate site gene therapy
US8226629B1 (en) 2002-04-01 2012-07-24 Ekos Corporation Ultrasonic catheter power control
WO2005039504A2 (en) * 2003-10-24 2005-05-06 Eisai Co., Ltd. Compounds and methods for treating toll-like receptor 2-related diseases and conditions
US7840263B2 (en) * 2004-02-27 2010-11-23 Cardiac Pacemakers, Inc. Method and apparatus for device controlled gene expression
US10182833B2 (en) 2007-01-08 2019-01-22 Ekos Corporation Power parameters for ultrasonic catheter
EP2170181B1 (en) 2007-06-22 2014-04-16 Ekos Corporation Method and apparatus for treatment of intracranial hemorrhages
WO2016201136A1 (en) 2015-06-10 2016-12-15 Ekos Corporation Ultrasound catheter
WO2019210272A1 (en) * 2018-04-27 2019-10-31 Seattle Children's Hospital (D/B/A Seattle Children's Research Institute) Ultrasound-mediated gene and drug delivery
CA3172591A1 (en) 2020-03-24 2021-09-30 Douglas Anthony KERR Non-viral dna vectors and uses thereof for expressing gaucher therapeutics
CN115667530A (en) 2020-03-24 2023-01-31 世代生物公司 Non-viral DNA vectors and their use for expressing factor IX therapeutics
WO2024040222A1 (en) 2022-08-19 2024-02-22 Generation Bio Co. Cleavable closed-ended dna (cedna) and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR8107560A (en) * 1981-11-19 1983-07-05 Luiz Romariz Duarte ULTRASONIC STIMULATION OF BONE FRACTURE CONSOLIDATION
DE69132031T2 (en) * 1990-12-20 2000-07-13 Arch Development Corp., The University Of Chicago CONTROL OF GENE EXPRESSION THROUGH IONIZING RADIATION
US5571797A (en) * 1994-05-11 1996-11-05 Arch Development Corporation Method of inducing gene expression by ionizing radiation
US5556372A (en) * 1995-02-15 1996-09-17 Exogen, Inc. Apparatus for ultrasonic bone treatment

Also Published As

Publication number Publication date
WO1999025385A1 (en) 1999-05-27

Similar Documents

Publication Publication Date Title
EP0742287B8 (en) Modified nucleic acid probes
AU7679394A (en) A method of nucleic acid sequencing
AU4635597A (en) Gene synthesis method
AU1390699A (en) A method of increasing nucleic acid synthesis with ultrasound
AU4326797A (en) A method of nucleic acid sequencing
AU7323194A (en) Synthesis of branched nucleic acids
AU1518699A (en) Array of functionalized micro-electrodes
AU6591798A (en) Nucleic acid catalysts
AU1450699A (en) Methods of nucleic acid detection
AU3745599A (en) Noncloning technique for expressing a gene of interest
AU9100598A (en) Method for the preparation of a probe for nucleic acid hybridization
AU6761496A (en) Computational analysis of nucleic acid information defines bnding sites
AU6519696A (en) A method for determining the integrity of nucleic acid
AU8234898A (en) Characterising nucleic acid
AU7208394A (en) Improved nucleic acid reactions
AU6194298A (en) A process for the preparation of moenomycin A
AU8798098A (en) Ultrasonic transducer
AU6376698A (en) Improved nucleic acid assays
AU5897298A (en) Midloop ultrasonic instrument
AUPO882497A0 (en) A method of genotyping
AU7937798A (en) A method of producing transformed cells of barley
AU8234798A (en) Categorising nucleic acid
AU7368596A (en) Nucleic acid reactions
AU4609301A (en) Method of identifying a nucleic acid sequence
AU5539096A (en) Nucleic acid sequencing

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase